APA (7th ed.) Citation

S, W., C, L., T, Z., B, Z., Y, J., H, W., . . . X, W. (2022). Pentamidine Alleviates Inflammation and Lipopolysaccharide-Induced Sepsis by Inhibiting TLR4 Activation via Targeting MD2. Frontiers in pharmacology, 13, 835081. https://doi.org/10.3389/fphar.2022.835081

Chicago Style (17th ed.) Citation

S, Wu, Lin C, Zhang T, Zhang B, Jin Y, Wang H, Li H, Wang Y, and Wang X. "Pentamidine Alleviates Inflammation and Lipopolysaccharide-Induced Sepsis by Inhibiting TLR4 Activation via Targeting MD2." Frontiers in Pharmacology 13 (2022): 835081. https://doi.org/10.3389/fphar.2022.835081.

MLA (9th ed.) Citation

S, Wu, et al. "Pentamidine Alleviates Inflammation and Lipopolysaccharide-Induced Sepsis by Inhibiting TLR4 Activation via Targeting MD2." Frontiers in Pharmacology, vol. 13, 2022, p. 835081, https://doi.org/10.3389/fphar.2022.835081.